Literature DB >> 20637903

Four novel RSK2 mutations in females with Coffin-Lowry syndrome.

Dorota Jurkiewicz1, Aleksandra Jezela-Stanek, Elzbieta Ciara, Dorota Piekutowska-Abramczuk, Monika Kugaudo, Maria Gajdulewicz, Krystyna Chrzanowska, Ewa Popowska, Małgorzata Krajewska-Walasek.   

Abstract

Coffin-Lowry syndrome (CLS) is an X-linked semi-dominant disorder caused by mutations in the RSK2 gene and characterized by moderate to severe mental retardation, characteristic facial features, skeletal deformities, and tapering fingers in males. Females are usually much more mildly and variably affected thus more difficult to diagnose. In this study, molecular genetic analysis was carried out in four female patients presenting features of Coffin-Lowry syndrome. The probands were sporadic cases with no affected males in their families. The molecular analysis of the RSK2 gene revealed four novel mutations, including two frameshift and one missense mutation identified by sequencing, and one large deletion detected by multiplex ligation-dependent probe amplification (MLPA) analysis. Females exhibited a random X-chromosome inactivation pattern. To our knowledge, this is the first report of applying MLPA in the diagnostics of CLS and the first description of a large deletion in a CLS female. These results support including screening for large rearragements in the genetic analysis of female CLS patients.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20637903     DOI: 10.1016/j.ejmg.2010.07.006

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  2 in total

1.  A Bizarre Gait as a Result of Overlapping Functional Disorder With Coffin-Lowry Syndrome.

Authors:  Ana Brás; Alexandra Pedruco; Sofia Maia; Isabel Fineza; Ana Morgadinho; Conceição Bento
Journal:  Mov Disord Clin Pract       Date:  2019-05-22

2.  Growth Concerns in Coffin-Lowry Syndrome: A Case Report and Literature Review.

Authors:  Ying Lv; Liuyan Zhu; Jing Zheng; Dingwen Wu; Jie Shao
Journal:  Front Pediatr       Date:  2019-01-25       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.